These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 14086382)
1. [CYTOLOGICAL STUDIES ON HORMONAL ACTION IN THE TREATMENT OF PROSTATIC CARCINOMA]. BUCHBERGER HG; BAUCHWITZ MA Z Urol; 1963; 56():411-20. PubMed ID: 14086382 [No Abstract] [Full Text] [Related]
3. THE TREATMENT OF METASTATIC PROSTATIC CANCER WITH DITHIZONE (DIPHENYLTHIOCARBAZONE). MACKENZIE AR; BHISITKUL IP; WHITMORE WF Invest Urol; 1963 Nov; 1():229-37. PubMed ID: 14102153 [No Abstract] [Full Text] [Related]
4. [The prognostic significance of alkaline and acid phosphatase levels in the hormonal treatment of patients with prostatic carcinoma]. Mulders PF; Debruyne FM Ned Tijdschr Geneeskd; 1987 Aug; 131(32):1399-402. PubMed ID: 3658014 [No Abstract] [Full Text] [Related]
5. [POSSIBILITIES OF "GUIDED" ENDOCRINE-SURGICAL TREATMENT IN CANCER OF THE PROSTATE]. GIANNONI R; ZINI S; MARCELLI G Arch Ital Urol; 1964 Apr; 36():423-40. PubMed ID: 14146744 [No Abstract] [Full Text] [Related]
6. Studies on prostatic cancer. I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941. Huggins C; Hodges CV J Urol; 2002 Feb; 167(2 Pt 2):948-51; discussion 952. PubMed ID: 11905923 [No Abstract] [Full Text] [Related]
7. PROGNOSTICATION OF CARCINOMA OF THE PROSTATE METASTATIC TO THE SKELETON BY RADIOLOGICAL STUDIES. SCHIRMER HK; RICHARDS GJ J Urol; 1964 Dec; 92():714-20. PubMed ID: 14241206 [No Abstract] [Full Text] [Related]
8. [The acid and alkaline phosphatase activity in the serum of patients with prostatic cancer. The effect of endocrine therapy]. Thijs LG; Poelman JR; Noll WL Ned Tijdschr Geneeskd; 1969 Jul; 113(30):1303-9. PubMed ID: 5802998 [No Abstract] [Full Text] [Related]
9. [Effect of estrogens and stilbenes on the hyaluronidase enzyme system; study of the etiology of body swelling and edema in endocrine therapy of prostatic carcinoma]. EUFINGER H; THURAU K Langenbecks Arch Klin Chir Ver Dtsch Z Chir; 1956; 281(6):573-82. PubMed ID: 13347138 [No Abstract] [Full Text] [Related]
11. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES]. BRENEZ J Acta Urol Belg; 1964 Jan; 32():100-3. PubMed ID: 14111370 [No Abstract] [Full Text] [Related]
12. [THE VALUE OF BIOLOGICAL EXAMINATIONS IN THE DIFFERENTIAL DIAGNOSIS OF PROSTATIC DISEASES]. MICHON J Acta Urol Belg; 1964 Jan; 32():85. PubMed ID: 14111385 [No Abstract] [Full Text] [Related]
13. Carcinoma of the prostate: a review. I. Incidence, etiology, pathology, and diagnosis. Blackard CE J Lancet; 1967 Dec; 87(12):477-84 contd. PubMed ID: 4866874 [No Abstract] [Full Text] [Related]
14. [Prognosis and treatment of prostatic carcinoma]. Klug W Zentralbl Chir; 1968 Mar; 93(10):362-6. PubMed ID: 5674208 [No Abstract] [Full Text] [Related]
15. Responsiveness of uroepithelium to estrogens as an indication of dose response in prostatic carcinoma. Silk MR J Surg Oncol; 1970; 2(3):199-202. PubMed ID: 5520838 [No Abstract] [Full Text] [Related]
16. [CONSIDERATIONS ON A NEW SYNTHETIC ESTROGEN IN THE THERAPY OF CARCINOMA OF THE PROSTATE (CHLOROTRIANISENE, TACE)]. CALDERINI G; GAGLIARDI V Minerva Urol; 1964; 16():53-8. PubMed ID: 14158352 [No Abstract] [Full Text] [Related]
17. New assays for prostatic acid phosphatase and alkaline phosphatase isoenzymes. Pontes JE Urology; 1981 Mar; 17(Suppl 3):38-9. PubMed ID: 7010753 [No Abstract] [Full Text] [Related]